Copper Metabolism Concerns Copper metabolism concerns represent theoretical risk of copper accumulation with prolonged use, though no documented cases of copper toxicity at recommended doses exist in literature
Topical application targets localized skin concerns
See the medication that's still working in your body
Those with type 1 diabetes or insulin-dependent type 2 diabetes must consult their endocrinologist before fasting on GLP-1s, as fasting reduces calorie intake and can increase hypoglycemia risk without medication adjustment
While much of the current research points towards potential anti-inflammatory benefits (e.g., in psoriasis), it's theoretically plausible that GLP-1 receptor activation could subtly alter the skin's immune response to environmental stressors, including UV radiation
Among the most groundbreaking of these medications is retatrutide , an investigational triple agonist peptide that targets not one, but three key metabolic hormone receptors